13D/13G Filings - Eventide Asset Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
12:13 pm
Sale
2024-12-31 13G Zentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC 4,475,054
6.280%
-2,615,054decrease
(-36.88%)
Filing
History
2025-02-14
12:11 pm
Sale
2024-12-31 13G Xometry, Inc.
XMTR
Eventide Asset Management, LLC 3,151,897
6.720%
-1,266,767decrease
(-28.67%)
Filing
History
2025-02-14
12:08 pm
Sale
2024-12-31 13G Nektar Therapeutics
NKTR
Eventide Asset Management, LLC 6,650,000
3.610%
-2,750,000decrease
(-29.26%)
Filing
History
2025-02-14
12:06 pm
Sale
2024-12-31 13G Mirum Pharmaceuticals, Inc.
MIRM
Eventide Asset Management, LLC 2,606,938
5.430%
-838,425decrease
(-24.33%)
Filing
History
2025-02-14
12:03 pm
Sale
2024-12-31 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC 1,234,834
3.730%
-621,152decrease
(-33.47%)
Filing
History
2025-02-14
12:01 pm
Purchase
2024-12-31 13G Inozyme Pharma, Inc.
INZY
Eventide Asset Management, LLC 2,220,000
3.460%
2,220,000increase
(New Position)
Filing
History
2025-02-14
11:56 am
Sale
2024-12-31 13G Aura Biosciences, Inc.
AURA
Eventide Asset Management, LLC 4,080,605
8.170%
-1,722,077decrease
(-29.68%)
Filing
History
2025-02-05
5:59 pm
Purchase
2025-01-31 13G Beta Bionics, Inc.
BBNX
Eventide Asset Management, LLC 4,857,041
11.320%
4,857,041increase
(New Position)
Filing
History
2024-11-14
12:27 pm
Sale
2024-09-30 13G Xometry, Inc.
XMTR
Eventide Asset Management, LLC 4,418,664
9.480%
-1,309,106decrease
(-22.86%)
Filing
History
2024-11-14
12:25 pm
Purchase
2024-09-30 13G Mirum Pharmaceuticals, Inc.
MIRM
Eventide Asset Management, LLC 3,445,363
7.220%
751,782increase
(+27.91%)
Filing
History
2024-11-14
12:24 pm
Sale
2024-09-30 13G Marinus Pharmaceuticals, Inc.
MRNS
Eventide Asset Management, LLC 0
0.000%
-4,529,997decrease
(Position Closed)
Filing
History
2024-11-14
12:23 pm
Sale
2024-09-30 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC 1,855,986
5.610%
-336,225decrease
(-15.34%)
Filing
History
2024-11-14
12:21 pm
Sale
2024-09-30 13G Korro Bio, Inc.
KRRO
Eventide Asset Management, LLC 391,166
4.210%
-155,159decrease
(-28.40%)
Filing
History
2024-11-14
12:19 pm
Purchase
2024-09-30 13G Inozyme Pharma, Inc.
INZY
Eventide Asset Management, LLC 4,134,436
6.440%
954,599increase
(+30.02%)
Filing
History
2024-11-14
12:18 pm
Sale
2024-09-30 13G Celldex Therapeutics, Inc.
CLDX
Eventide Asset Management, LLC 3,332,005
5.030%
-298,008decrease
(-8.21%)
Filing
History
2024-11-14
12:17 pm
Purchase
2024-09-30 13G Nektar Therapeutics
NKTR
Eventide Asset Management, LLC 9,400,000
5.110%
9,400,000increase
(New Position)
Filing
History
2024-11-06
2:47 pm
Sale
2024-10-31 13G Zentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC 7,090,108
9.970%
-4,469,867decrease
(-38.67%)
Filing
History
2024-08-09
09:43 am
Sale
2024-07-31 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC 2,192,211
6.650%
-810,620decrease
(-27.00%)
Filing
History
2024-02-14
12:49 pm
Purchase
2023-12-31 13G Mirum Pharmaceuticals, Inc.
MIRM
Eventide Asset Management, LLC 2,693,581
5.780%
636,581increase
(+30.95%)
Filing
History
2024-02-14
12:43 pm
Sale
2023-12-31 13G Annexon, Inc.
ANNX
Eventide Asset Management, LLC 0
0.000%
-3,626,508decrease
(Position Closed)
Filing
History
Goto 0, 1, 2, 3, Next